Employees Retirement System of Texas’s Sana Biotechnology SANA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-34,669
Closed -$123K 551
2025
Q3
$123K Buy
34,669
+5,213
+18% +$18.8K ﹤0.01% 373
2025
Q2
$80K Hold
29,456
﹤0.01% 447
2025
Q1
$49K Hold
29,456
﹤0.01% 263
2024
Q4
$48K Hold
29,456
﹤0.01% 309
2024
Q3
$123K Hold
29,456
﹤0.01% 319
2024
Q2
$161K Hold
29,456
﹤0.01% 300
2024
Q1
$295K Buy
29,456
+16,460
+127% +$123K ﹤0.01% 306
2023
Q4
$53K Buy
+12,996
New +$47.9K ﹤0.01% 337

Other funds holding SANA

Employees Retirement System of Texas's SANA Position: Q4 2025 in Review

Employees Retirement System of Texas sold out of Sana Biotechnology (SANA) in Q4 2025, closing a stake of 34,669 shares — an estimated $123K sold.

Employees Retirement System of Texas first reported a position in SANA in Q4 2023 and held it in 8 quarters. The position peaked at $295K in Q1 2024. 203 funds tracked by Wall St. Rank hold SANA as of Q4 2025.

  • Employees Retirement System of Texas reported no remaining Sana Biotechnology position as of Q4 2025 after selling out during the quarter.
  • Employees Retirement System of Texas sold 34,669 Sana Biotechnology shares in Q4 2025, an estimated $123K.
  • Employees Retirement System of Texas first reported a position in Sana Biotechnology in Q4 2023 and held it in 8 quarters.
  • Employees Retirement System of Texas's Sana Biotechnology position peaked at $295K in Q1 2024.
  • 203 funds tracked by Wall St. Rank held Sana Biotechnology as of Q4 2025.

Based on Employees Retirement System of Texas's 13F filing for Q4 2025, filed 9 Feb 2026.